Recombinant antibodies: engineering and production in yeast and bacterial hosts
KJ Jeong, SH Jang, N Velmurugan - Biotechnology journal, 2011 - Wiley Online Library
After the appearance of the first FDA‐approved antibody 25 years ago, antibodies have
become major therapeutic agents in the treatment of many human diseases, including …
become major therapeutic agents in the treatment of many human diseases, including …
Recombinant antibodies: Engineering and production in yeast and bacterial hosts
KJ Jeong, SH Jang, V Natarajan - Biotechnology Journal, 2011 - experts.umn.edu
After the appearance of the first FDA-approved antibody 25 years ago, antibodies have
become major therapeutic agents in the treatment of many human diseases, including …
become major therapeutic agents in the treatment of many human diseases, including …
Recombinant antibodies: engineering and production in yeast and bacterial hosts
KJ Jeong, SH Jang… - Biotechnology journal, 2011 - pubmed.ncbi.nlm.nih.gov
After the appearance of the first FDA-approved antibody 25 years ago, antibodies have
become major therapeutic agents in the treatment of many human diseases, including …
become major therapeutic agents in the treatment of many human diseases, including …
Recombinant antibodies: Engineering and production in yeast and bacterial hosts
KJ Jeong, SH Jang, N Velmurugan - Biotechnology Journal, 2011 - Wiley Online Library
After the appearance of the first FDA‐approved antibody 25 years ago, antibodies have
become major therapeutic agents in the treatment of many human diseases, including …
become major therapeutic agents in the treatment of many human diseases, including …
Recombinant antibodies: Engineering and production in yeast and bacterial hosts
KJ Jeong, SH Jang, N Velmurugan - Biotechnology Journal, 2011 - pure.kaist.ac.kr
After the appearance of the first FDA-approved antibody 25 years ago, antibodies have
become major therapeutic agents in the treatment of many human diseases, including …
become major therapeutic agents in the treatment of many human diseases, including …
Recombinant antibodies: engineering and production in yeast and bacterial hosts.
KJ Jeong, SH Jang, N Velmurugan - Biotechnology Journal, 2011 - europepmc.org
After the appearance of the first FDA-approved antibody 25 years ago, antibodies have
become major therapeutic agents in the treatment of many human diseases, including …
become major therapeutic agents in the treatment of many human diseases, including …
Recombinant antibodies: Engineering and production in yeast and bacterial hosts
K Jeong, SH Jang, N Velmurugan - BIOTECHNOLOGY …, 2011 - koasas.kaist.ac.kr
After the appearance of the first FDA-approved antibody 25 years ago, antibodies have
become major therapeutic agents in the treatment of many human diseases, including …
become major therapeutic agents in the treatment of many human diseases, including …
[引用][C] Recombinant antibodies: Engineering and production in yeast and bacterial hosts
KJ Jeong, SH Jang, N Velmurugan - Biotechnology Journal, 2010 - cir.nii.ac.jp